Recent article for leronlimab as therapy for TNBC.
Post# of 151637

Research article
Open Access
Published: 23 January 2021
Leronlimab, a humanized monoclonal antibody to CCR5, blocks breast cancer cellular metastasis and enhances cell death induced by DNA damaging chemotherapy
https://breast-cancer-research.biomedcentral....21-01391-1

